palladon 20 mg/ ml
mundipharma as - hydromorfonhydroklorid - injeksjons-/infusjonsvæske, oppløsning - 20 mg/ ml
tanonalla 40 mg / 20 mg
sandoz - københavn - oksykodonhydroklorid / naloksonhydrokloriddihydrat - depottablett - 40 mg / 20 mg
tanonalla 5 mg / 2.5 mg
sandoz - københavn - oksykodonhydroklorid / naloksonhydrokloriddihydrat - depottablett - 5 mg / 2.5 mg
tanonalla 10 mg / 5 mg
sandoz - københavn - oksykodonhydroklorid / naloksonhydrokloriddihydrat - depottablett - 10 mg / 5 mg
tanonalla 20 mg / 10 mg
sandoz - københavn - oksykodonhydroklorid / naloksonhydrokloriddihydrat - depottablett - 20 mg / 10 mg
tanonalla 30 mg / 15 mg
sandoz - københavn - oksykodonhydroklorid / naloksonhydrokloriddihydrat - depottablett - 30 mg / 15 mg
baraclude 0.5 mg
orifarm as - entekavirmonohydrat - tablett, filmdrasjert - 0.5 mg
baraclude 0.5 mg
abacus medicine a/s - entekavirmonohydrat - tablett, filmdrasjert - 0.5 mg
baraclude 1 mg
abacus medicine a/s - entekavirmonohydrat - tablett, filmdrasjert - 1 mg
nuvaxovid
novavax cz, a.s. - sars cov-2 (original) recombinant spike protein, sars-cov-2 (omicron xbb.1.5) recombinant spike protein - covid-19 virus infection - covid-19 vaccines - nuvaxovid is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 12 years of age and older. bruk av denne vaksinen skal være i samsvar med offisielle anbefalinger. nuvaxovid xbb. 5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 12 years of age and older. bruk av denne vaksinen skal være i samsvar med offisielle anbefalinger.